Dr. Kroog is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Regeneron Pharmaceuticals
777 Old Saw Mill River Road
Tarrytown, NY 10591Phone+1 914-847-7209
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1992 - 1995
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1989 - 1992
- Weill Cornell MedicineClass of 1989
Certifications & Licensure
- NY State Medical License 1990 - 2026
Publications & Presentations
PubMed
- First-in-Human Dose-Escalation Study of Fianlimab, an Antilymphocyte Activation Gene-3 Antibody, with Cemiplimab in Patients with Advanced Malignancies.Nehal J Lakhani, Kyriakos P Papadopoulos, Melissa Lynne Johnson, Haeseong Park, Ding Wang
Clinical Cancer Research. 2024-12-16 - 5 citationsPhase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma.Omid Hamid, Karl D Lewis, Amy Weise, Meredith McKean, Kyriakos P Papadopoulos
Journal of Clinical Oncology. 2024-08-20 - 8 citationsLinvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma.Naresh Bumma, Joshua Richter, Sundar Jagannath, Hans C Lee, James E Hoffman
Journal of Clinical Oncology. 2024-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: